Wenchu Lin

2.6k total citations
50 papers, 1.5k citations indexed

About

Wenchu Lin is a scholar working on Molecular Biology, Oncology and Materials Chemistry. According to data from OpenAlex, Wenchu Lin has authored 50 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 21 papers in Oncology and 9 papers in Materials Chemistry. Recurrent topics in Wenchu Lin's work include Lung Cancer Research Studies (18 papers), Cancer therapeutics and mechanisms (10 papers) and Epigenetics and DNA Methylation (9 papers). Wenchu Lin is often cited by papers focused on Lung Cancer Research Studies (18 papers), Cancer therapeutics and mechanisms (10 papers) and Epigenetics and DNA Methylation (9 papers). Wenchu Lin collaborates with scholars based in China, United States and Hong Kong. Wenchu Lin's co-authors include Sharon Dent, Xing Bian, Hong Li, Xiaotong Lv, Xiaolin Wang, Hongji Liu, Liying Ma, Xiangfu Meng, Yong Qian and Jingxin Li and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Genes & Development.

In The Last Decade

Wenchu Lin

50 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenchu Lin China 24 1.0k 304 247 224 194 50 1.5k
Gongwei Wu China 15 814 0.8× 474 1.6× 209 0.8× 183 0.8× 189 1.0× 17 1.3k
Junnian Zhou China 20 709 0.7× 283 0.9× 228 0.9× 118 0.5× 267 1.4× 46 1.4k
Yun Zhou China 24 857 0.8× 369 1.2× 186 0.8× 228 1.0× 400 2.1× 66 1.6k
Ruiying Zhao United States 17 930 0.9× 351 1.2× 465 1.9× 98 0.4× 118 0.6× 47 1.5k
Xiangjun Meng China 20 781 0.7× 290 1.0× 384 1.6× 86 0.4× 139 0.7× 41 1.4k
Yuanfei Yao China 20 682 0.7× 334 1.1× 328 1.3× 103 0.5× 181 0.9× 49 1.3k
Yuliang Ran China 23 689 0.7× 348 1.1× 345 1.4× 194 0.9× 225 1.2× 55 1.5k
Jia You China 17 635 0.6× 318 1.0× 167 0.7× 140 0.6× 107 0.6× 33 1.1k
Chaoyang Wu China 20 683 0.7× 283 0.9× 170 0.7× 311 1.4× 283 1.5× 52 1.4k

Countries citing papers authored by Wenchu Lin

Since Specialization
Citations

This map shows the geographic impact of Wenchu Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenchu Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenchu Lin more than expected).

Fields of papers citing papers by Wenchu Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenchu Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenchu Lin. The network helps show where Wenchu Lin may publish in the future.

Co-authorship network of co-authors of Wenchu Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Wenchu Lin. A scholar is included among the top collaborators of Wenchu Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenchu Lin. Wenchu Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Xianli, et al.. (2024). HMGN1 loss sensitizes lung cancer cells to chemotherapy. Scientific Reports. 14(1). 10386–10386. 1 indexed citations
2.
Zhang, Shuai, et al.. (2024). BRCA1 orchestrates the response to BI-2536 and its combination with alisertib in MYC-driven small cell lung cancer. Cell Death and Disease. 15(7). 551–551. 2 indexed citations
3.
Zhou, Ke, Shaobo Zhang, Yijun Lu, et al.. (2023). Carbon-coated magnetite nanoclusters with NIR-II absorbance for imaging-guided photothermal-chemodynamic synergistic therapy. Science China Materials. 66(6). 2492–2503. 9 indexed citations
4.
Qian, Yong, Shuai Zhang, Xingyu Wang, et al.. (2022). NIR-II responsive PEGylated nickel nanoclusters for photothermal enhanced chemodynamic synergistic oncotherapy. Theranostics. 12(8). 3690–3702. 28 indexed citations
5.
Wang, Xiaolin, et al.. (2022). Emerging roles of circular RNAs in gastric cancer metastasis and drug resistance. Journal of Experimental & Clinical Cancer Research. 41(1). 218–218. 35 indexed citations
6.
Ma, Liying, Yue‐Biao Zhang, Xiaolin Wang, et al.. (2022). Darinaparsin (ZIO-101) enhances the sensitivity of small-cell lung cancer to PARP inhibitors. Acta Pharmacologica Sinica. 44(4). 841–852. 3 indexed citations
7.
Zhou, Mengxue, Jiayu Zhang, Xiaomeng Cai, et al.. (2022). Tumor-Penetrating and Mitochondria-Targeted Drug Delivery Overcomes Doxorubicin Resistance in Lung Cancer. Chinese Journal of Polymer Science. 41(4). 525–537. 15 indexed citations
8.
Lin, Wenchu, et al.. (2022). Comprehensive analysis of the expression, prognosis, and immune infiltrates for CHDs in human lung cancer. Discover Oncology. 13(1). 29–29. 5 indexed citations
9.
Xu, Changzhi, Lanlan Zhang, Xiaoyi Liu, et al.. (2022). Sheep tail fat inhibits the proliferation of non-small-cell lung cancer cells in vitro and in vivo. Frontiers in Pharmacology. 13. 917513–917513. 3 indexed citations
10.
Li, Hong, et al.. (2021). FK228 sensitizes radioresistant small cell lung cancer cells to radiation. Clinical Epigenetics. 13(1). 41–41. 12 indexed citations
11.
Bian, Xing, Xiaolin Wang, Qiu‐Yan Zhang, et al.. (2020). The MYC Paralog-PARP1 Axis as a Potential Therapeutic Target in MYC Paralog-Activated Small Cell Lung Cancer. Frontiers in Oncology. 10. 565820–565820. 5 indexed citations
12.
Shi, Wenhao, Ke Deng, Xiaoli Liu, et al.. (2020). Combinations of proteasome inhibitors with obatoclax are effective for small cell lung cancer. Acta Pharmacologica Sinica. 42(8). 1298–1310. 7 indexed citations
13.
Liu, Xiaoli, Wei Wang, Hong Li, et al.. (2019). A high-throughput drug screen identifies auranofin as a potential sensitizer of cisplatin in small cell lung cancer. Investigational New Drugs. 37(6). 1166–1176. 15 indexed citations
14.
Sheng, Yi, Wei Wang, Bo Hong, et al.. (2018). Upregulation of KIF20A correlates with poor prognosis in gastric cancer. Cancer Management and Research. Volume 10. 6205–6216. 37 indexed citations
15.
Lin, Wenchu, Hideo Watanabe, Shouyong Peng, et al.. (2014). Dynamic Epigenetic Regulation by Menin During Pancreatic Islet Tumor Formation. Molecular Cancer Research. 13(4). 689–698. 49 indexed citations
16.
Watanabe, Hideo, Joshua M. Francis, Michele Sue‐Ann Woo, et al.. (2013). Integrated cistromic and expression analysis of amplified NKX2-1 in lung adenocarcinoma identifies LMO3 as a functional transcriptional target. Genes & Development. 27(2). 197–210. 53 indexed citations
17.
Martínez‐Cerdeño, Verónica, et al.. (2012). N-Myc and GCN5 Regulate Significantly Overlapping Transcriptional Programs in Neural Stem Cells. PLoS ONE. 7(6). e39456–e39456. 50 indexed citations
18.
Lin, Wenchu, et al.. (2007). Developmental potential of Gcn5−/− embryonic stem cells in vivo and in vitro. Developmental Dynamics. 236(6). 1547–1557. 48 indexed citations
19.
Lin, Wenchu & Sharon Dent. (2006). Functions of histone-modifying enzymes in development. Current Opinion in Genetics & Development. 16(2). 137–142. 76 indexed citations
20.
Zhang, Ke, Wenchu Lin, John Latham, et al.. (2005). The Set1 Methyltransferase Opposes Ipl1 Aurora Kinase Functions in Chromosome Segregation. Cell. 122(5). 723–734. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026